Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has provided an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has announced that its board of directors will meet on April 29, 2025, to review and approve the unaudited financial results for the first quarter of 2025. This meeting is significant as it provides insights into the company’s financial health and operational performance, which are crucial for stakeholders and investors monitoring the company’s market position and future prospects.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is based in Guangzhou, China, and is involved in the development and sale of various medicinal products and health-related services.
YTD Price Performance: 3.49%
Average Trading Volume: 30,548
Technical Sentiment Signal: Buy
Current Market Cap: $5.48B
Learn more about 0874 stock on TipRanks’ Stock Analysis page.